Depth of anaesthesia in patients undergoing transfemoral transcatheter aortic valve implantation with ‘conscious sedation and local anaesthesia’—a secondary exploratory analysis of the randomised SOLVE-TAVI trial
Editor-Transfemoral transcatheter aortic valve implantation (TAVI) has become the standard of care for older patients with symptomatic, severe aortic stenosis 1 and is increasingly performed under local anaesthesia with conscious sedation (LA-CS). 2 The randomised multicentre SOLVE-TAVI trial in 447 patients with severe aortic stenosis undergoing TAVI revealed that general anaesthesia (GA) or LA-CS resulted in similar short-and long-term outcomes with respect to a combined primary endpoint including all-cause mortality, stroke, myocardial infarction, acute kidney injury, and infection mandating antibiotic treatment. [3][4]][5] As a part of the study protocol, anaesthesia depth during the intervention was continuously monitored with the bispectral index (BIS, Covidien-Medtronic, Minneapolis, MN,
Authors
- Matthias Heringlake (ORCID: https://orcid.org/0000-0001-6949-7113)
- Hans‐Josef Feistritzer (ORCID: https://orcid.org/0000-0002-6208-5316)
- Sascha Treskatsch (ORCID: https://orcid.org/0000-0002-0549-7680)
- Jöerg Ender (ORCID: https://orcid.org/0000-0002-8507-5321)
- Hölger Thiele (ORCID: https://orcid.org/0000-0002-0169-998X)
- Ursula Vigelius-Rauch
Institutions
- Leipzig University of Applied Sciences (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- University Hospital Augsburg (DE)
- Humboldt-Universität zu Berlin (DE)
- Leipzig Heart Institute (DE)
- University Hospital Leipzig (DE)
- Franklin University (US)
- Leipzig University (DE)
Publication Details
- Journal
- BJA Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.bjao.2025.100502
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Stiftung für Herzforschung